Results 11 to 20 of about 5,598,449 (384)
The Lancet, 2021 The management of prostate cancer continues to evolve rapidly, with substantial advances being made in understanding the genomic landscape and biology underpinning both primary and metastatic prostate cancer. Similarly, the emergence of more sensitive imaging methods has improved diagnostic and staging accuracy and refined surveillance strategies ...
Sandhu, S +5 more
semanticscholar +11 more sources
Chinese Prostate Cancer Consortium (CPCC) Chinese expert consensus on advanced prostate cancer: clinical management of patients with metastatic hormone-sensitive prostate cancer treated by initial novel hormone therapy (2022 edition) [PDF]
Zhongguo aizheng zazhi, 2022 Metastatic hormone-sensitive prostate cancer (mHSPC) is a male health concern requiring continuous attention. In 2021, an important update was included in domestic and international guidelines regarding the recommendations of initial systemic therapy for
Chinese Prostate Cancer Consortium (CPCC), YE Dingwei, HUANG Jian
doaj +1 more source
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
New England Journal of Medicine, 2021 BACKGROUND Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic castration-resistant prostate cancer.
O. Sartor +19 more
semanticscholar +1 more source
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer Network, 2023 The NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, post-treatment monitoring, and treatment of recurrence ...
E. Schaeffer +37 more
semanticscholar +1 more source
Ca, 2021 This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
H. Sung +6 more
semanticscholar +1 more source
African Journal of Urology, 2021 Background Cancer of the prostate (CaP) is a public health problem that affects the male genitourinary system causing a significant threat to men’s quality of life (QoL).
Elizabeth O. Akin-Odanye +5 more
doaj +1 more source
Ca, 2023 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
R. Siegel +3 more
semanticscholar +1 more source
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Molecules, 2022 Simple Summary Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease.
M. Sekhoacha +5 more
semanticscholar +1 more source
BMC Urology, 2022 Background To report the feasibility, oncological and functional outcomes of salvage robot-assisted radical prostatectomy (sRARP) for recurrent prostate cancer (PCa) after irreversible electroporation (IRE).
Alexandar Blazevski +11 more
doaj +1 more source
Accuracy of elastic fusion biopsy in daily practice: results of a multicenter study of 2115 patients [PDF]
, 2018 OBJECTIVES: To assess the accuracy of Koelis fusion biopsy for the detection of prostate cancer and clinically significant prostate cancer in the everyday practice.
Albisinni S +30 more
core +1 more source